DE3869670D1 - Latex fuer die immobilisierung von physiologisch aktiven verbindungen und reaktiver latex, der diesen latex verwendet. - Google Patents

Latex fuer die immobilisierung von physiologisch aktiven verbindungen und reaktiver latex, der diesen latex verwendet.

Info

Publication number
DE3869670D1
DE3869670D1 DE8888106859T DE3869670T DE3869670D1 DE 3869670 D1 DE3869670 D1 DE 3869670D1 DE 8888106859 T DE8888106859 T DE 8888106859T DE 3869670 T DE3869670 T DE 3869670T DE 3869670 D1 DE3869670 D1 DE 3869670D1
Authority
DE
Germany
Prior art keywords
latex
reactive
active compounds
physiologically active
immobilizing physiologically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8888106859T
Other languages
English (en)
Inventor
C O Nitto Denko Corp Kihara
C O Nitto Denko Corp Mori
C O Nitto Denko Corp Watanabe
C O Nitto Denko Corp Tsuji
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nitto Denko Corp
Original Assignee
Nitto Denko Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nitto Denko Corp filed Critical Nitto Denko Corp
Application granted granted Critical
Publication of DE3869670D1 publication Critical patent/DE3869670D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F212/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an aromatic carbocyclic ring
    • C08F212/02—Monomers containing only one unsaturated aliphatic radical
    • C08F212/04—Monomers containing only one unsaturated aliphatic radical containing one ring
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/082—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/082—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • C12N11/087—Acrylic polymers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE8888106859T 1987-04-30 1988-04-28 Latex fuer die immobilisierung von physiologisch aktiven verbindungen und reaktiver latex, der diesen latex verwendet. Expired - Lifetime DE3869670D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62108701A JPH0810224B2 (ja) 1987-04-30 1987-04-30 生理活性物質固定化用ラテツクス及びこのラテツクスを用いるラテツクス試薬

Publications (1)

Publication Number Publication Date
DE3869670D1 true DE3869670D1 (de) 1992-05-07

Family

ID=14491433

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888106859T Expired - Lifetime DE3869670D1 (de) 1987-04-30 1988-04-28 Latex fuer die immobilisierung von physiologisch aktiven verbindungen und reaktiver latex, der diesen latex verwendet.

Country Status (4)

Country Link
EP (1) EP0295402B1 (de)
JP (1) JPH0810224B2 (de)
CA (1) CA1301647C (de)
DE (1) DE3869670D1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2816414B2 (ja) * 1989-01-20 1998-10-27 ディアグノスティカ スタゴ サブミクロン粒子，調整及び免疫反応診断学における用途
FR2642174B1 (fr) * 1989-01-20 1994-03-25 Diagnostica Stago Particules submicroniques, utilisation dans le domaine des reactions immunologiques du type antigene
GB8907534D0 (en) * 1989-04-04 1989-05-17 Dow Europ Sa Monovinylidene aromatic and conjugated diene copolymer coating compositions comprising sulfoalkyl monomeric emulsifier
US5274027A (en) * 1989-04-04 1993-12-28 The Dow Chemical Company Monovinylidene aromatic and conjugated diene copolymer coating compositions comprising sulfoalkyl monomeric emulsifier
JP2714862B2 (ja) * 1989-08-11 1998-02-16 日東電工株式会社 免疫学的測定法
WO2007063616A1 (ja) * 2005-11-30 2007-06-07 Nihon University 超高感度ｃ－反応性タンパク質測定試薬及び測定方法
CN101542286B (zh) * 2006-10-16 2014-08-20 三菱化学美迪恩斯株式会社 高分子微粒的制备方法
JP5541474B2 (ja) * 2007-08-31 2014-07-09 株式会社豊田中央研究所 単分散架橋ポリマー微粒子及びその製造方法
JP5594038B2 (ja) * 2009-10-14 2014-09-24 住友ベークライト株式会社 粒子保存溶液および粒子の保存方法
EP2833146B1 (de) * 2012-03-30 2016-12-14 Sekisui Medical Co., Ltd. Latexteilchen für einen agglutinationstest
WO2014051098A1 (ja) * 2012-09-27 2014-04-03 積水メディカル株式会社 粒子凝集測定用ラテックス粒子
KR102505384B1 (ko) * 2016-08-31 2023-03-06 에이껜 가가꾸 가부시끼가이샤 다른 방식으로 항원을 고정화한 항원 담지 불용성 담체 입자를 사용하는 항체 측정법, 항체 측정용 시약
WO2018216784A1 (ja) * 2017-05-24 2018-11-29 積水化学工業株式会社 測定試薬用ラテックス粒子、感作ラテックス粒子及び免疫比濁法用測定試薬
JP7399675B2 (ja) 2019-10-25 2023-12-18 キヤノン株式会社 粒子およびその製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL256198A (de) * 1959-09-23
DE1148747B (de) * 1961-01-18 1963-05-16 Basf Ag Verfahren zur Herstellung waessriger emulgatorfreier Dispersionen von Mischpolymerisaten, die Carboxylgruppenenthalten
EP0054685B1 (de) * 1980-12-23 1986-07-09 Roche Diagnostics GmbH Hydrophile Latexpartikel, Verfahren zu deren Herstellung und deren Verwendung

Also Published As

Publication number Publication date
EP0295402A3 (en) 1989-02-15
EP0295402A2 (de) 1988-12-21
JPH0810224B2 (ja) 1996-01-31
CA1301647C (en) 1992-05-26
EP0295402B1 (de) 1992-04-01
JPS63273060A (ja) 1988-11-10

Similar Documents

Publication Publication Date Title
DE3782394D1 (de) Immobilisiertes, physiologisch aktives material.
NO870240L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tieno-1,4-diazepiner.
FI904444A0 (fi) Aktiva limkompositioner.
DE3869670D1 (de) Latex fuer die immobilisierung von physiologisch aktiven verbindungen und reaktiver latex, der diesen latex verwendet.
DE69014166D1 (de) Aktive Matrix.
FI872733A0 (fi) Farmaceutiska kompositioner.
FI885256A (fi) Kalander med foerskjutbara lagerdelar.
ES2088965T3 (es) Derivados de rodanina aril-sustituidos.
DE69005048D1 (de) Matrix von Heteroübergang-Photodioden.
FI873798A0 (fi) Aminoglykosidsteroider, foerfarande foer deras framstaellning, deras anvaendning samt farmaceutiska kompositioner innehaollande desamma.
FI872313A0 (fi) Farmaceutiska kompositioner.
NO870533D0 (no) Terapeutisk aktive 3-alkoksy-2-aminopropylaminer.
IT8820388A0 (it) Composizione oftalmologica.
FI873799A (fi) Aminoglykosidsteroider, foerfarande foer deras framstaellning, deras anvaendning samt farmaceutiska kompositioner innehaollande desamma.
FI884545A (fi) Farmaceutisk komposition, som innehaoller avsvaellande piperidinoalkanolfoereningar.
NO875262L (no) Fremgangsmaate for aa komprimere kornformige formstoffer, spesielt stoepeformstoffer.
NO881768D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner.
EP0246861A3 (en) Pharmaceutical composition based on crotoxine, process for preparing the active component and the pharmaceutical composition
FI880320A0 (fi) Foerfarande foer framstaellning av n,n-(dibensohexatrienylen) urinaemnen.
NO164973C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive gem-dihalo- og tetrahalo-1,2-diamino-4,9,-diaza-dodecaner.
DE3761561D1 (de) N,n-bis-(4-fluorophenyl)carbamoylacetohydroxamsaeure und diese enthaltende pharmazeutische zusammensetzungen.
TR25921A (tr) PESTISID ETKINLIGI HAIZ PESTISID ÖZELLIKTE BISIKLOOKTANLAR,BUNLARI IHTIVA EDEN FORMüLASYONLAR VE HAZIRLANMALARINA MAHSUS USULLER.
GB2185478B (en) Novel e-valerolactam, pharmacologically active compositions thereof, processes for the preparation thereof and their medical use
IT8622051A1 (it) Composizioni farmaceutiche ad attivita' cicatrizzante
NO880639D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive oksimetere av 2,6-dioksabicyklo (3, 3, 0)oktanoner.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition